🇨🇦 Short Acting Beta 2 Agonist in Canada

Short Acting Beta 2 Agonist (Short Acting Beta 2 Agonist) regulatory status in Canada.

Marketing authorisation

Short Acting Beta 2 Agonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Short Acting Beta 2 Agonist approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Short Acting Beta 2 Agonist in Canada?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.